This is a long-lasting skin condition that causes itchy welts or hives. The welts appear and disappear over many days or weeks, usually every day. It's not caused by an infection, but the exact reason why the body makes these welts is still being studied.
Every report comes from a Lived member, sent anonymously.
Have you tried Zyrtec (Cetirizine) for Chronic Hives?
Chronic hives, known medically as chronic urticaria, means itchy, raised welts (wheals), deeper swelling of the skin (angioedema), or both that keep coming back for more than six weeks. Each welt usually fades within a day without leaving a mark, but new ones keep appearing, often daily or almost daily. Angioedema most often affects the lips, eyelids, hands or feet. It tends to feel tight, burning or painful rather than itchy, and it can take up to three days to settle. There are two main forms. In chronic spontaneous urticaria (once called chronic idiopathic urticaria), hives appear without any definite trigger. In chronic inducible urticaria, hives appear reliably after a specific physical trigger, such as cold, pressure, heat, sunlight, sweating or rubbing of the skin. Many people have more than one form. Chronic hives is rarely dangerous, but the constant itch, visible swelling and broken sleep take a real toll: studies have found its effect on overall health comparable to conditions such as rheumatoid arthritis.
Hives form when mast cells, immune cells in the skin, release histamine and other chemicals that make small blood vessels leak fluid and nerves itch. In more than half of people with chronic spontaneous urticaria, the immune system itself is responsible: it makes antibodies that switch these mast cells on, which makes the condition a form of autoimmunity. In others, the cause is not yet known. Chronic hives sometimes begins after an infection, and it is linked with thyroid disease and other autoimmune conditions. Many people suspect a food, but food allergy is very rarely the cause of chronic hives. Some things do not cause the condition but can make flares worse. These include infections, stress and anti-inflammatory pain relievers called NSAIDs, such as ibuprofen and aspirin, which worsen hives in up to a quarter of people. Acetaminophen is usually a safer choice for pain. Anyone taking low-dose aspirin for heart protection should talk with their clinician rather than stop it on their own. In the inducible forms, the specific trigger, such as cold air or water, a tight waistband or a rise in body temperature during exercise, brings on hives whenever exposure passes that person's threshold.
Chronic hives is diagnosed mainly from a person's history and the skin itself. A clinician asks how long hives have been returning, how long each welt lasts, whether swelling occurs and what seems to make it worse, including medicines. Because hives may have faded by the time of the appointment, photos taken during a flare are genuinely useful. For chronic spontaneous urticaria, testing is deliberately limited. A complete blood count and a blood test for inflammation (C-reactive protein or sedimentation rate) help rule out other illnesses. Specialists may also check total IgE, an allergy-related antibody, and thyroid antibodies, which can hint at the type of autoimmunity and how well certain treatments are likely to work. Broad allergy panels and extensive screening are not recommended, because a positive food test usually does not explain chronic hives. When an inducible form is suspected, the clinician tests the trigger directly, for example by firmly stroking the skin or holding a cold or warm device against the forearm to find the level that brings on hives. Part of the assessment is ruling out conditions that look similar. Welts that each last more than a day or leave bruising can point to urticarial vasculitis, an inflammation of small blood vessels that may need a skin biopsy. Repeated swelling without any hives raises other possibilities, such as hereditary angioedema or swelling caused by ACE inhibitor blood pressure medicines, which do not respond to antihistamines and are treated differently. Clinicians also measure how active and how well controlled the hives are. With the weekly Urticaria Activity Score, a person rates hives and itch from 0 to 3 each day for seven days, for a total of up to 42. The Urticaria Control Test asks four questions about the past four weeks and is scored out of 16; a score of 12 or more means the hives are well controlled.
The goal of treatment is complete control, meaning no hives, no swelling and normal sleep, using as little medicine as needed. Treatment works in steps, moving up when symptoms persist and back down when they settle. The first step is a non-drowsy, second-generation antihistamine, such as cetirizine (Zyrtec), fexofenadine (Allegra) or loratadine (Claritin), taken every day rather than only when hives appear, since regular use prevents new hives from forming. If a standard dose is not enough after a week or two, clinicians often raise the dose of the same antihistamine to as much as four times the label dose. This is off-label, but international guidelines recommend it and it has a long safety record; doses beyond four times are not recommended. Older, sedating antihistamines are not advised for regular use, because they cause drowsiness and impair sleep quality, concentration and driving. When high-dose antihistamines still do not control chronic spontaneous urticaria, three add-on treatments approved by the US Food and Drug Administration are available. Omalizumab (Xolair), an injected antibody that blocks the allergy antibody IgE, is the most established. It is given every four weeks, prevents both hives and swelling for many people, and its effect can build slowly. Because it can rarely cause a severe allergic reaction (anaphylaxis), treatment starts in a clinic with a period of observation after each injection. Dupilumab (Dupixent), an injected antibody also used for eczema and asthma, is approved from age 2 and can be a sensible choice for people who have those conditions as well, though its effect on hives appears somewhat smaller than that of omalizumab. Remibrutinib (Rhapsido), approved in 2025 for adults, is a twice-daily pill that blocks Bruton's tyrosine kinase, an enzyme involved in switching on mast cells. It needs no injections or routine lab monitoring, but it can cause bleeding, such as easy bruising, so it is paused around surgery and needs extra thought for people taking blood thinners. Remibrutinib is also approved for adults with symptomatic dermographism, the inducible form in which rubbing or scratching the skin raises welts. For severe hives that resist these options, specialists may use cyclosporine, an immune-suppressing medicine that can be effective but has more side effects with long-term use, so it is reserved for difficult cases. A short course of an oral steroid such as prednisone, usually no more than about 10 days, can calm a bad flare, but long-term steroid use is avoided because its side effects outweigh the benefit. Alongside medicine, avoiding personal aggravators such as NSAIDs and limiting exposure to the specific trigger in inducible forms can reduce flares, although this rarely controls the condition on its own.
Chronic hives tends to come and go over months or years, and how active it is can change from week to week. It usually fades over time, but no one can predict exactly when that will happen for a given person, and it can return after months or years of remission. Frequent swelling, very active hives, having an inducible form alongside the spontaneous one, or raised inflammation markers on blood tests tend to go with a longer course and a weaker response to antihistamines. High-dose antihistamines control symptoms for a large share of people, and the add-on treatments help many of those who still have hives. Finding the right step can take a few months of adjustment. Because the condition can quiet down on its own, clinicians typically review the need for treatment every three to six months and step it down once hives have stayed controlled. Keeping a simple daily record of hives and itch helps reveal patterns, such as flares after taking ibuprofen, and makes follow-up visits more concrete. Poor sleep, anxiety and low mood are common with chronic hives; they are part of the condition's burden and are worth raising, since they can be treated too.
See a clinician, ideally an allergist or dermatologist, if hives last more than a month or keep coming back, disturb sleep or daily life, or are not controlled by a daily antihistamine. Contact your care team if individual welts last longer than a day or leave bruises, if swelling happens without any hives, or if a treatment causes troubling side effects, such as unusual bleeding while taking remibrutinib. Swelling of the tongue or throat, trouble breathing or swallowing, wheezing or feeling faint, including after an omalizumab injection, can signal a severe allergic reaction: use an epinephrine auto-injector if one has been prescribed, and call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chronic Hives is like, what's helped you, or ask the community a question.